Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaiser, N.
Right arrow Articles by Ktorza, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, N.
Right arrow Articles by Ktorza, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:138-145, 2005
© 2005 by the American Diabetes Association, Inc.

Dynamic Changes in ß-Cell Mass and Pancreatic Insulin During the Evolution of Nutrition-Dependent Diabetes in Psammomys obesus

Impact of Glycemic Control

Nurit Kaiser1, Michal Yuli1, Gökhan Üçkaya1, Andrei I. Oprescu1, Marie-France Berthault2, Catherine Kargar2, Marc Y. Donath3, Erol Cerasi1, and Alain Ktorza2

1 Endocrinology and Metabolism Service, Department of Medicine, Hadassah—Hebrew University Medical Center, Jerusalem, Israel
2 Laboratoire de Physiopathologie de la Nutrition, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7059, Universite Paris 7, Paris, France
3 Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, Zurich, Switzerland

Recent studies ascribe a major role to pancreatic ß-cell loss in type 2 diabetes. We investigated the dynamics of ß-cell mass during diabetes evolution in Psammomys obesus, a model for nutrition-dependent type 2 diabetes, focusing on the very early and the advanced stages of the disease. P. obesus fed a high-calorie diet for 26 days developed severe hyperglycemia, ß-cell degranulation, and markedly reduced pancreatic insulin content. Reducing calories for 7 days induced normoglycemia in 90% of the animals, restoring ß-cell granulation and insulin content. To dissociate effects of diet from blood glucose reduction, diabetic animals received phlorizin for 2 days, which normalized glycemia and increased the pancreatic insulin reserve to 50% of control, despite a calorie-rich diet. During diabetes progression, ß-cell mass decreased initially but recovered spontaneously to control levels, despite persistent hyperglycemia. Strikingly, however, ß-cell mass did not correlate with degree of hyperglycemia or pancreatic insulin content. We conclude that reduced insulin reserve is the main cause of diabetes progression, whereas irreversible ß-cell mass reduction is a late event in P. obesus. The rapid recovery of the pancreas by phlorizin-induced normoglycemia implies a causal relationship between hyperglycemia and islet dysfunction. Similar mechanisms could be operative during the evolution of type 2 diabetes in humans.


Address correspondence and reprint requests to Nurit Kaiser, Endocrinology and Metabolism Service, Department of Medicine, Hadassah—Hebrew University Medical Center, P.O. Box 12000, Jerusalem 91120, Israel. E-mail: kaiser{at}md.huji.ac.il


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.-F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, et al.
mTOR Inhibition by Rapamycin Prevents {beta}-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes
Diabetes, April 1, 2008; 57(4): 945 - 957.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. Wente, A. M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, G. E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada
Fibroblast Growth Factor-21 Improves Pancreatic {beta}-Cell Function and Survival by Activation of Extracellular Signal-Regulated Kinase 1/2 and Akt Signaling Pathways
Diabetes, September 1, 2006; 55(9): 2470 - 2478.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Kaiser, R. Nesher, M. Y. Donath, M. Fraenkel, V. Behar, C. Magnan, A. Ktorza, E. Cerasi, and G. Leibowitz
Psammomys Obesus, a Model for Environment-Gene Interactions in Type 2 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S137 - S144.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.